China Pharmaceuticals and Healthcare Report Q1 2015

Business Monitor International
December 17, 2014
204 Pages - SKU: BMI5416301
Countries covered: China

China Pharmaceuticals and Healthcare Report Q1 2015

BMI View: Improvements in intellectual property protection, an ageing population and increasing accessto healthcare will drive the robust growth of China's pharmaceutical market. This will attract foreign drugmanufacturers despite the downside risks of pharmaeconomics and the government's crackdown on illegalpractices.

Headline Expenditure Projections

Pharmaceuticals: CNY532.4bn (USD86.6bn) in 2013 to CNY616.1bn (USD100.6bn) in 2014; +15.7%in local currency and +16.1% in US dollar terms.

Healthcare: CNY3,230.8bn (USD525.4bn) in 2013 to CNY3,733.1bn (USD609.2bn) in 2014; +15.6% inlocal currency terms and +15.9% in US dollar terms. Forecast has been upgraded from Q414 due toupgraded growth in private health expenditure.



More Prescription Drugs reports by Business Monitor International

Taiwan Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Taiwan Pharmaceuticals and Healthcare Report Q1 2015BMI View: Taiwan is one of the most attractive and stable prospects in the region for pharmaceutical andhealthcare investment, ...
Switzerland Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Switzerland Pharmaceuticals and Healthcare Report Q1 2015BMI View: The Swiss government will need to develop policies to maintain the country's long-termattractiveness as a site for ...
Sudan Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Sudan Pharmaceuticals and Healthcare Report Q1 2015BMI View: The already depreciating Sudanese pound will come under further strain should oil pricescontinue their decline as oil ...
Saudi Arabia Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Saudi Arabia Pharmaceuticals and Healthcare Report Q1 2015BMI View: We expect heavy investment into Saudi Arabia's healthcare sector to continue, particularly asthe government sees the ...
See all reports like this >>

More China Prescription Drugs reports

Osteoporosis Drugs Markets in China by Asia Market Information & Development Company
Osteoporosis Drugs Markets in ChinaChina's demand for Osteoporosis Drugs has grown at a fast pace in the past decade. In the next decade, both production ...
Mental Illness Drugs Markets in China by Asia Market Information & Development Company
Mental Illness Drugs Markets in ChinaChina's demand for Mental Illness Drugs has grown at a fast pace in the past decade. In the next decade, ...
Hypertension Drugs Markets in China by Asia Market Information & Development Company
Hypertension Drugs Markets in ChinaChina's demand for Hypertension Drugs has grown at a fast pace in the past decade. In the next decade, both production ...
Blood Disease Drugs Markets in China by Asia Market Information & Development Company
Blood Disease Drugs Markets in ChinaChina's demand for Blood Disease Drugs has grown at a fast pace in the past decade. In the next decade, ...
See all reports like this >>

 

SELECT A LICENSE

    Report with 3 quarterly updates  USD 1,295  
    Report with 3 quarterly updates
3 User License
  USD 1,945  
    Report with 3 quarterly updates
5 User License
  USD 2,500  
    Report with 3 quarterly updates
Departmental/Site License
  USD 2,995  
    Global Site License Fulfilled by Publisher  USD 6,995  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!